An act relating to the use and maintenance of epinephrine at child care facilities

This bill aims to ensure that child care facilities are equipped with epinephrine, a medication used to treat severe allergic reactions. It outlines the responsibilities for the use and maintenance of these medications in such facilities. The goal is to enhance the safety and health of children who may experience allergic emergencies while in care.

VT H0574 is a house bill in the Vermont 2025-2026 Session, sponsored by Leanne Harple (D), currently “Introduced” since January 6, 2026.

We track 1,717 Vermont bills this session, 4 of them sponsored by Leanne Harple.

Supporters of this bill would argue that it is a crucial step in protecting children from life-threatening allergic reactions. By ensuring that child care facilities have access to epinephrine, the bill promotes a safer environment for all children, especially those with known allergies. This legislation demonstrates a commitment to child health and safety.

Critics may argue that the bill places an additional burden on child care facilities, which could struggle with the costs and logistics of maintaining epinephrine supplies. They might also express concerns about the potential for misuse or over-reliance on medication rather than addressing underlying allergy management. Some may view this as an unnecessary government mandate that complicates operations for child care providers.